The medical tourism market size was valued at USD 77.81 billion in 2025 and is projected to grow from USD 89.79 billion in 2026 to USD 285.67 billion by 2034, growing at a CAGR of 15.57% during the forecast period (2026-2034).
Download Free Sample Report to Get Detailed Insights.
Patients travel to lower-cost destinations to bridge the gap between treatment costs. High healthcare expenses and long waiting times in developed countries push patients toward destinations offering affordable surgeries and procedures without compromising quality.
Hospitals invest in international accreditation to influence trust among patients. Accreditation by global bodies improves credibility, reassures foreign patients, and strengthens destination competitiveness.
Medical tourism packages are expanding because patients prefer end-to-end coordination. Integrated offerings that combine treatment, accommodation, travel, and post-procedure care simplify planning and improve patient experience.
Large treatment cost differentials increase international patient demand. Advanced procedures such as cardiac surgery, knee replacement, and cosmetic surgery cost 50–70% less in destinations like India, Thailand, and Mexico, which shifts patient demand toward these markets and increases procedure volumes for local providers.
Government-supported medical visa reforms expand supply-side accessibility. The introduction of e-medical visas and national promotion programs in countries such as India, Thailand, and the United Arab Emirates simplifies entry for foreign patients, increases inbound medical travel, and strengthens overall market growth through higher patient inflows.
Concentration of internationally trained specialists increases destination competitiveness. Hospitals in key hubs employ doctors trained in the US and Europe and invest in advanced clinical infrastructure, which raises treatment quality, strengthens global patient trust, and increases demand for cross-border medical services.
Lack of standardized international regulatory frameworks restrains market coordination. Inconsistent legal and compliance requirements across countries increase liability risks for providers and patients, which slows adoption of cross-border medical services and limits market growth.
Limited portability of international health insurance restrains patient mobility. Insurers in countries such as the US and Canada do not comprehensively cover overseas treatments, resulting in patients facing higher out-of-pocket costs, which reduces demand for medical tourism.
Capacity constraints at major hospitals restrain service availability. High patient volumes create longer waiting times for international patients, which weakens destination attractiveness and slows growth in inbound medical travel.
Government-supported regional medical tourism hubs act as an opportunity because they improve coordination and visibility. Public backing strengthens infrastructure, simplifies patient navigation, and increases inbound patient volumes.
Integration of wellness and preventive screenings raises per-patient spending. Combining medical procedures with health checks, rehabilitation, and wellness services expands service scope and revenue potential.
The expansion of fertility tourism attracts cross-border patients. International providers such as IVI RMA expand access to assisted reproduction services, which increases demand from global patients seeking affordable and timely treatment.
Development of long-stay rehabilitation and recovery programs opens new growth avenues as patients seek comprehensive outcomes. Extended recovery packages that combine medical care, physiotherapy, and accommodation increase length of stay, raise total spending per patient, and improve destination competitiveness.
Cancer treatment held the largest share of the treatment type segment at 18.46% in 2025. The dominance of this segment is driven by the high global burden of cancer and the significant cost differentials between developed and emerging countries for oncology procedures. Patients frequently travel internationally for advanced therapies such as targeted therapy, immunotherapy, precision oncology, and complex surgical interventions at comparatively lower costs. The availability of internationally accredited oncology centers and shorter waiting times further strengthens this segment’s contribution to overall market revenue.
Orthopedic treatment is anticipated to register a CAGR of 16.30% during the forecast period. Procedures such as joint replacement, spine surgery, and minimally invasive orthopedic interventions are major contributors to medical travel. High treatment costs and long waiting periods in developed countries encourage patients to seek affordable and high-quality orthopedic procedures abroad. Technological advancements in robotic-assisted surgeries and improved post-operative rehabilitation services are further supporting growth in this segment.
The private hospitals & clinics segment is expected to register a growth rate of 16.33% during the forecast period. The growth is attributed to advanced infrastructure, internationally accredited facilities, personalized patient care services, and dedicated departments. Many private healthcare providers offer bundled packages covering treatment, accommodation, and post-operative care, enhancing their attractiveness to international patients.
The public hospitals segment is expected to register a CAGR of 16.24% during the forecast period. In several countries, government-supported hospitals provide high-quality specialized treatments at competitive pricing. Public healthcare institutions with strong reputations in oncology, cardiology, and organ transplantation continue to attract international patients, particularly where healthcare systems are well-regulated and internationally recognized.
The inbound international segment dominated the market with a share of 62.60%. This growth is driven by increasing cross-border patient mobility from high-cost healthcare countries to destinations offering affordable yet high-quality treatment. Factors such as favorable exchange rates, internationally accredited hospitals, medical visa facilitation, and the growing reputation of emerging healthcare hubs significantly contribute to this segment’s leadership.
The outbound international segment is anticipated to register a considerable growth rate of 16.88% during the forecast period. Patients travel abroad seeking specialized treatments not readily available in their home countries, access to advanced technologies, or better clinical outcomes. Rising globalization of healthcare services and increasing awareness about international treatment options are supporting steady growth in this segment.
Download Free Sample Reportto Get Detailed Insights.
The market in the Asia Pacific had a share of 43.70% in 2025. The growth is supported by large volumes of international patient inflows to Thailand, Malaysia, and India. Various government policies, featuring streamlined visa processes and promotional partnerships, have boosted accessibility and increased confidence among patients and created demand for quality, affordable care. Cardiac surgery, orthopedics, oncology, fertility treatment, and cosmetic procedures cost 50–70% less than in the US or Europe, which directly shifts patient demand toward Asia Pacific destinations.
Source: Straits Analysis
Latin America is emerging as the fastest-growing region, growing at a CAGR of 17.56% from 2026 to 2034. This growth is augmented by increasing procedural volumes and expanding aesthetic medical tourism. Millions of medical tourists travel each year for dental, bariatric, and orthopedic surgeries in Mexico. The increasing global recognition of Colombia in aesthetic and specialized surgeries positions Latin America as a major regional market. Geographic proximity to North America increases patient inflow. Short travel times and cultural familiarity encourage patients from the US and Canada to seek treatment in nearby Latin American destinations.
The North American market is driven by the rising trend of outbound medical travelers to undergo novel treatments under skilled healthcare professionals. Advanced medical facilities in the US and Canada, where complex medical treatments are easily available, attract both domestic and international medical travelers. Cosmetic surgery, dental care, fertility treatment, and bariatric surgery often lack full insurance coverage in the region, which results in patients exploring international options.
Europe is a booming market, driven by the presence of highly specialized treatment centers and surgical technologies in countries such as Germany and Switzerland, which provide services to patients undergoing complex treatment procedures. Healthcare directives between EU countries allow patients to seek medical treatment in any member country, and reimbursement schemes stimulate the growth of medical tourism.
The Middle East & Africa market is propelled by government investments in world-class specialty hospitals and free zones such as Dubai Healthcare City. An increase in medical travel from neighboring GCC countries for fertility treatment, orthopedic procedures, and cosmetic surgeries also supports market growth. Premium accommodation, concierge services, and recovery facilities enhance treatment journeys, which increases destination attractiveness. Investments by private hospital groups and international healthcare operators increase service availability and shorten waiting times.
The medical tourism market is moderately fragmented, and competition is stiff among international hospital groups, specialized facilitators, and regional healthcare service providers. Key players compete based on advanced medical technologies, internationally accredited facilities, experienced specialists, and integrated travel care packages. Emerging players compete via low treatment costs and personalized services.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a Healthcare Lead with over 7 years of industry experience, specializing in Healthcare IT. She provides comprehensive market insights on digital health, electronic medical records, telehealth, and healthcare analytics. Debashree’s research supports organizations in adopting technology-driven healthcare solutions, improving patient care, and achieving operational efficiency in a rapidly transforming healthcare ecosystem.
We are featured on:
sales@straitsresearch.com